News & Articles
Selected Filters:
Roche launches Liver Disease Panel, the first certified algorithm suite for chronic liver disease management
New digital and biomarker-integrated solution supports early detection, risk assessment, and disease monitoring
MHRA launches consultation on new UK rare disease therapies framework to accelerate patient access
Proposed regulatory approach aims to enable earlier patient access and support innovative trial designs
AdrenoMed advances personalized septic shock therapy as new sepsis guidelines and U.S. policy highlight urgent unmet need
2026 Surviving Sepsis Campaign Guidelines and U.S. SEPSIS Act reinforce the need to close persistent therapeutic gaps in septic shock and improve survival through personalized, evidence-based approaches
Renalytix and Carna Health partner to advance kidney disease screening and management
Integrated diagnostics and digital health platform aims to enable earlier intervention and improve outcomes in chronic kidney disease
Lutèce Dynamics announces its first commercial VertX installation to advance infection research at SLAS Europe 2025
First commercial sale of VertX, the cutting-edge, label-free live microscope module at William Morey General Hospital, enabling high‑resolution imaging of biopsies to support infection research and personalized treatment
Yourgene Health launches insight DPYD assay
Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients
Fujirebio Europe secures CE mark for Lumipulse G pTau 217 Plasma assay under IVDR
Lumipulse G pTau 217 Plasma test supports identification of amyloid pathology in patients with cognitive decline
Candida auris and emerging diagnostics: A strategic look ahead in antimicrobial resistance
As Candida auris and carbapenem-resistant Enterobacterales rise, join us online to explore how emerging approaches such as next-generation sequencing and rapid susceptibility testing may support antimicrobial stewardship — plus, ask your questions in the live Q&A
HiArc launches HiArc Ctrl to accelerate the development of medical devices
HiArc Ctrl combines embedded hardware and software tools to streamline prototyping and regulated workflow development
Roche receives CE mark for breakthrough Alzheimer’s plasma pTau217 blood test
Elecsys pTau217 is the first single-assay blood test designed to identify or rule out amyloid pathology across primary and secondary care
Blood test approach shows potential to predict disease progression and treatment response
Study demonstrates how RNA‑based analysis could enable early prediction of clinical outcomes across multiple conditions
Roche enters merger agreement to acquire PathAI and expand AI‑driven diagnostics capabilities
Acquisition strengthens Roche’s digital pathology and companion diagnostic portfolio to advance precision medicine
Changing the future of food allergy testing with advanced diagnostic methods
Explore advances in lab testing methods moving food allergy diagnosis beyond skin pricks and into molecular precision
Lucent Diagnostics and Tempus AI partner to expand access to Alzheimer’s blood biomarker testing
Collaboration integrates LucentAD Complete into AI‑driven clinical workflows to support earlier detection and treatment decisions
Myriad Genetics expands access to MyChoice Test for prostate cancer patients in Japan
Approval by Japan’s MHLW enables use of MyChoice Test as a companion diagnostic for Lynparza in prostate cancer
CDC certification expands access to gold‑standard equivalent testosterone testing from Siemens Healthineers
Certification reaffirms assay results are aligned with specialized mass spectrometry testing method
Labcorp launches FDA-cleared blood test to support initial Alzheimer's disease assessment in primary care
Elecsys pTau-181 test helps clinicians rule out Alzheimer's disease by identifying patients unlikely to have amyloid pathology
Streck launches new MDx-Chex controls for respiratory low-plex testing
New MDx‑Chex for RLP controls support full‑process verification for respiratory molecular assays
How external quality controls are transforming molecular diagnostics
Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics
Bruker expands MALDI Biotyper and IR Biotyper workflows for microbial identification and outbreak management
New portfolio enhancements reflect Bruker’s commitment to advancing integrated, high‑performance solutions that support laboratories in addressing evolving infectious disease challenges
Watchmaker Genomics launches Stellar RT-qPCR and qPCR Kits
Watchmaker Genomics presented new data highlighting the performance of its amplification technologies, including the Stellar RT-qPCR and qPCR Kits, at ESCMID 2026
What laboratories need to know as hemophilia gene therapy expands
After years of research, gene therapy is entering clinics worldwide, bringing new expectations and new responsibilities for diagnostic laboratories
Empowering the modern laboratory through free accredited clinical education
Discover how SelectScience clinical CE webinars are supporting biomedical scientists and laboratory professionals in achieving diagnostic excellence during Medical Lab Professionals Week 2026
The critical role that medical laboratory professionals play in post-transplant care
In this guest editorial, Richard Knight Senior Director, Medical Affairs, Thermo Fisher Scientific, explores how success in transplantation is measured in years, not hours, and how lab professionals provide the critical data needed to navigate the high-stakes journey of post-operative care
























